3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Endocrine
1
Conditions
Multiple Endocrine Neoplasia Type 1
1
Emergencies
1
Interventions
Eating
5
Standard of Care
4
Radiofrequency Ablation
4
Exercise
4
Endoscopic Mucosal Resection
4
Surgical Procedures, Operative
3
Radiosurgery
3
Adrenalectomy
3
lutetium Lu 177 dotatate
2
Yoga
2
Saline Solution
2
Robotic Surgical Procedures
2
Resistance Training
2
Proton Therapy
2
Propofol
2
Palliative Care
2
Octreotide
2
Magnetic Resonance Imaging
2
Lutetium-177
2
Liquid Biopsy
2
Interviews as Topic
2
Hydrocortisone
2
Diet, Mediterranean
2
Diet
2
Desflurane
2
Data Collection
2
Conversion to Open Surgery
2
Control Groups
2
Calcium
2
3-Iodobenzylguanidine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Ketorolac
×
Endocrine
×
Clear all
NCT01471639
2025-08-15
Sprix
The Cleveland Clinic
Phase NA
Completed
37 enrolled
7 charts